HC Wainwright Research Analysts Decrease Earnings Estimates for Transcat, Inc. (NASDAQ:TRNS)

Transcat, Inc. (NASDAQ:TRNS) – HC Wainwright cut their FY2024 earnings per share estimates for Transcat in a report issued on Tuesday, April 16th. HC Wainwright analyst S. Buck now anticipates that the scientific and technical instruments company will earn $1.35 per share for the year, down from their previous forecast of $1.45. HC Wainwright currently has a “Buy” rating and a $124.00 price objective on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.36 per share. HC Wainwright also issued estimates for Transcat’s Q4 2024 earnings at $0.53 EPS.

Separately, TheStreet upgraded Transcat from a “c+” rating to a “b” rating in a research report on Wednesday, January 31st.

Transcat Price Performance

Shares of TRNS stock traded down $3.84 on Wednesday, reaching $104.71. The company’s stock had a trading volume of 48,433 shares, compared to its average volume of 37,953. The company has a quick ratio of 2.81, a current ratio of 3.37 and a debt-to-equity ratio of 0.01. Transcat has a 12-month low of $74.89 and a 12-month high of $115.41. The company has a market capitalization of $924.59 million, a P/E ratio of 81.12 and a beta of 0.59. The stock’s 50 day simple moving average is $108.78 and its 200-day simple moving average is $101.86.

Transcat (NASDAQ:TRNS) last posted its earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. Transcat had a return on equity of 9.32% and a net margin of 4.16%. The firm had revenue of $65.17 million for the quarter, compared to the consensus estimate of $63.36 million.

Institutional Trading of Transcat

Several large investors have recently modified their holdings of the business. Conestoga Capital Advisors LLC lifted its holdings in Transcat by 0.6% in the fourth quarter. Conestoga Capital Advisors LLC now owns 762,861 shares of the scientific and technical instruments company’s stock worth $83,404,000 after buying an additional 4,805 shares during the period. Fred Alger Management LLC lifted its holdings in Transcat by 6.1% in the first quarter. Fred Alger Management LLC now owns 727,225 shares of the scientific and technical instruments company’s stock worth $65,007,000 after buying an additional 41,563 shares during the period. Wasatch Advisors LP lifted its holdings in Transcat by 13.3% in the fourth quarter. Wasatch Advisors LP now owns 701,099 shares of the scientific and technical instruments company’s stock worth $76,651,000 after buying an additional 82,458 shares during the period. BlackRock Inc. lifted its holdings in Transcat by 8.1% in the second quarter. BlackRock Inc. now owns 494,947 shares of the scientific and technical instruments company’s stock worth $42,224,000 after buying an additional 37,225 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in Transcat by 12.3% in the fourth quarter. Vanguard Group Inc. now owns 477,799 shares of the scientific and technical instruments company’s stock worth $52,238,000 after buying an additional 52,421 shares during the period. 98.34% of the stock is owned by institutional investors.

Insider Buying and Selling at Transcat

In other Transcat news, CEO Lee D. Rudow sold 5,000 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $111.30, for a total transaction of $556,500.00. Following the sale, the chief executive officer now owns 108,478 shares in the company, valued at $12,073,601.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Charles P. Hadeed sold 700 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $113.00, for a total transaction of $79,100.00. Following the transaction, the director now directly owns 22,678 shares of the company’s stock, valued at $2,562,614. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Lee D. Rudow sold 5,000 shares of the firm’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $111.30, for a total value of $556,500.00. Following the transaction, the chief executive officer now directly owns 108,478 shares in the company, valued at $12,073,601.40. The disclosure for this sale can be found here. Insiders have sold 8,073 shares of company stock worth $900,023 over the last 90 days. Corporate insiders own 4.20% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.